ClearBridge Investments
FLGT icon

ClearBridge Investments’s Fulgent Genetics FLGT Stock Holding History

ClearBridge Investments’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,000
Closed -$5K – 1192
2017
Q3 		$5K Hold
1,000
– – ﹤0.01% 1123
2017
Q2 		$6K Buy
+1,000
New +$8.06K ﹤0.01% 1131

Other funds holding FLGT

MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments's FLGT Position: Q4 2017 in Review

ClearBridge Investments sold out of Fulgent Genetics (FLGT) in Q4 2017, closing a stake of 1,000 shares — an estimated $5K sold.

ClearBridge Investments first reported a position in FLGT in Q2 2017 and held it in 2 quarters. The position peaked at $6K in Q2 2017. 18 funds tracked by Wall St. Rank hold FLGT as of Q4 2017.

  • ClearBridge Investments reported no remaining Fulgent Genetics position as of Q4 2017 after selling out during the quarter.
  • ClearBridge Investments sold 1,000 Fulgent Genetics shares in Q4 2017, an estimated $5K.
  • ClearBridge Investments first reported a position in Fulgent Genetics in Q2 2017 and held it in 2 quarters.
  • ClearBridge Investments's Fulgent Genetics position peaked at $6K in Q2 2017.
  • 18 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2017.

Based on ClearBridge Investments's 13F filing for Q4 2017, filed 14 Feb 2018.